You're seeing this page as if you were . The main menu is still yours, though. Exit from immersion
Malt Strategy
Guillaume-Azad GündüzGG

Guillaume-Azad Gündüz

Business Development, Divestment, Acquisitions

€730/day
Paris, FR
3-7 years
Gestion de projet
Business development
industrie pharmaceutique
divestment
Fusions-acquisitions

Average response time: 1 hour

About Guillaume-Azad

Pharmacien avec une expertise en stratégie de développement, j’accompagne les laboratoires pharmaceutiques dans leurs projets de croissance externe (acquisitions, in-licensing, valorisation d’actifs) comme interne (gestion de portefeuille, positionnement). Grâce à une connaissance fine des marchés internationaux et des pratiques d’accès (pricing, market access), je contribue à maximiser la valeur des produits de santé à chaque étape de leur cycle de vie.
Pharmaceuticals

  • French

    Native or bilingual

  • English

    Fluent

Can work on-site
Paris (up to 50km)

Experience

  • SANOFI
    Divestment Project Lead
    PHARMACEUTICALS INDUSTRY
    January 2022 - April 2025 (3 years and 3 months)
    Paris, France
    • Managed the successful execution of post-closure activities for two global divestment projects, in antibiotics and anti inflammatory fields, involving over 117 SKUs, 13 INNs, and 24 brands, with transactions reaching €160 millions and €50 millions, spanning 22 & 16 countries.
    • Coordinated across multi-disciplinary teams for smooth transition of assets, including hundreds of marketing authorizations, ensuring operational continuity and compliance with legal and financial frameworks during the divestment of mature products.
    • Led commercial due diligence and project co-lead up to Signing for an international oncology bundle with 5 INNs, steering 60 markets analysis and articulating product value in the Information Memorandum and Teaser, which maximized the bundle's appeal during the co managed M&A divestment project.
    • Acted as the key contact point, undertaking international travel to directly engage with buyers and internal teams, rapidly addressing and mitigating issues for the transfer of life-saving drugs, exemplifying a diplomatic approach in critical scenarios. Reference: Marc TROPET, Global Divestment Lead, Sanofi, +33 6 32 22 58 29
    Communication Project Management Business analysis
  • ETHYPHARM
    Corporate & Business Development
    PHARMACEUTICALS INDUSTRY
    April 2021 - September 2021 (5 months)
    Saint-Cloud, France
    • Analyzed and selected de-risked Phase 3 molecules, leveraging market insights and competitive landscape data for strategic co-commercialization in the EU and China.
    • Spearheaded scouting initiatives to identify promising CNS and critical care molecules, aiming to fill portfolio gaps and extend the company's market reach.

Recommendations

Be the first to recommend Guillaume-Azad

Help this freelancer shine by sharing your experience working together.

These freelancer profiles also match your criteria

AgathaA

Agatha Frydrych

Backend Java Software Engineer

4.7

(3)

2

BaptisteB

Baptiste Duhen

Fullstack developer

4.6

(4)

5

AmedA

Amed Hamou

Senior Lead Developer

4

(2)

7

AudreyA

Audrey Champion

Web developer

4.3

(3)

4

Signup to reveal

Education

  • Pharmacien
    Université Paris-Saclay
    2023
    Pharmacien, section industrie pharmaceutique
  • Master of Science (Msc)
    TBS Education - BUSINESS SCHOOL
    2023
    Mastère, Manager commercial dans les industries de santé

Skill set

Project Management
Commercial

Categories